Search
You have searched for "dexamethasone"
Showing 1-10 of 99
COVID-19 fuelling education's tech disruption, deepening digital divide
TORONTO/NEW YORK (Reuters) - The COVID-19 pandemic deepened inequities in accessing and benefiting from education but the future of learning could be a more equal one, participants told Reuters Next panels on Monday.
Penang cops bust illegal medicine syndicate
GEORGE TOWN: A syndicate that processed illegal medicine has been crippled, with police arresting four people and seizing products worth RM14mil in the state.
Fourth iteration of COVID-19 treatment trial underway in U.S.
WASHINGTON, Nov. 25 (Xinhua) -- The U.S. National Institute of Allergy and Infectious Diseases (NIAID) announced on Wednesday that the fourth iteration of the Adaptive COVID-19 Treatment Trial (ACTT-4) has begun to enroll hospitalized COVID-19 adults who require supplemental oxygen.
‘We’re drowning’: COVID cases flood hospitals in America’s heartland
(Reuters) - Dr. Drew Miller knew his patient had to be moved.
Some Russian hospitals face shortages of COVID-19 drugs
MOSCOW (Reuters) - Some Russian hospitals are experiencing serious shortages of drugs used to treat COVID-19 and cannot restock because of panic buying, high demand and problems with a new labelling system, officials, distributors and doctors said.
Respiratory failure in COVID-19 usually not driven by cytokine storm: study
CHICAGO, Nov. 14 (Xinhua) -- A study from Washington University School of Medicine in St. Louis and St. Jude Children's Research Hospital in Memphis, Tennessee, suggests that only 4 percent of COVID-19 patients had the sky-high levels of immune molecules that signify a so-called "cytokine storm."
World's top intensive care body advises against remdesivir for sickest COVID patients
BRUSSELS (Reuters) - Antiviral remdesivir should not be used as a routine treatment for COVID-19 patients in critical care wards, the head of one of the world's top bodies representing intensive care doctors said, in a blow to the drug developed by U.S. firm Gilead
COVID-19 fatality rate down 30% since April, study finds
(Reuters) - The likelihood that a coronavirus infection will prove fatal has dropped by nearly a third since April due to improved treatment, researchers at the University of Washington’s Institute for Health Metrics and Evaluation (IHME) said on Thursday.
Antivirals, therapies for early intervention need of the hour to tackle COVID-19 - Fauci
(Reuters) - U.S. infectious disease expert Anthony Fauci said on Thursday that efforts are underway in the U.S. to push for the development of antivirals and other therapies for early intervention during the course of the COVID-19 respiratory illness.
Spotlight: World Health Assembly resumes as global COVID-19 cases exceed 50 mln
GENEVA, Nov. 9 (Xinhua) -- The resumed session of the 73rd World Health Assembly opened on Monday to address some of the most pressing global health issues and emergencies, including the COVID-19 pandemic that had claimed over 1.25 million lives and infected more than 50 million people worldwide.
